Currently, there are 51.91M common shares owned by the public and among those 49.04M shares have been available to trade.
The company’s stock has a 5-day price change of -6.02% and -20.06% over the past three months. WK shares are trading -38.67% year to date (YTD), with the 12-month market performance down to -18.99% lower. It has a 12-month low price of $60.50 and touched a high of $116.83 over the same period. WK has an average intraday trading volume of 770.97K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.42%, -8.55%, and -21.58% respectively.
Institutional ownership of Workiva Inc (NYSE: WK) shares accounts for 84.99% of the company’s 51.91M shares outstanding.
It has a market capitalization of $3.74B and a beta (3y monthly) value of 0.90. The earnings-per-share (ttm) stands at -$1.16. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.87% over the week and 2.84% over the month.
Analysts forecast that Workiva Inc (WK) will achieve an EPS of 0.05 for the current quarter, 0.33 for the next quarter and 1.7 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.05 while analysts give the company a high EPS estimate of 0.05. Comparatively, EPS for the current quarter was 0.16 a year ago. Earnings per share for the fiscal year are expected to increase by 11.41%, and 63.80% over the next financial year. EPS should grow at an annualized rate of 50.82% over the next five years, compared to 0.61% over the past 5-year period.
Looking at the support for the WK, a number of firms have released research notes about the stock. Exane BNP Paribas stated their Outperform rating for the stock in a research note on April 22, 2025, with the firm’s price target at $100. Stephens coverage for the Workiva Inc (WK) stock in a research note released on March 19, 2025 offered a Overweight rating with a price target of $111. Raymond James was of a view on January 03, 2025 that the stock is Outperform, while Stifel gave the stock Buy rating on December 18, 2024, issuing a price target of $102- $130. BMO Capital Markets on their part issued Outperform rating on November 07, 2024.
